6/13/2019 1:04:16 AM
Genentech Announces Positive Top Line Results From Phase III PEMPHIX Study
6/12/2019 1:04:59 AM
Genentech: FDA Grants Priority Review For Use Of Rituxan With Glucocorticoids
6/11/2019 2:24:40 AM
CMA Serves An Initial Enforcement Order On Roche-Spark Therapeutics Deal
6/11/2019 1:08:50 AM
Roche: Peter Voser To Step Down As Member Of Board Of Roche At The End Of June
6/11/2019 1:06:25 AM
Roche: FDAs Grants Accelerated Approval To Polivy With Bendamustine + Rituxan
6/11/2019 1:02:58 AM
Genentech Announces Positive Topline Results For NOBILITY
6/10/2019 1:07:38 AM
Roche, Spark Therapeutics Receive Request For Addl Information From FTC; Extends Tender Offer For Spark Therapeutics
6/4/2019 1:06:44 AM
Genentech Says Phase III BLOCKSTONE Study Meets Primary Endpoint
6/3/2019 1:02:16 AM
Genentech Announces Positive Topline Data From Two Phase III Multicenter Studies Of Xolair
6/2/2019 9:23:09 AM
Roche Announces Positive Additional Results Of Prespecified Exploratory Analysis From Phase III IMpower150 Study
5/31/2019 1:04:43 AM
Roche And GE Healthcare Launch NAVIFY Tumor Board
5/28/2019 10:04:23 AM
Roche Unveils First In Vitro Diagnostic IHC Test To Detect ROS1 Protein In Cancers
5/23/2019 10:03:01 AM
Roche Gets FDA Clearance To Expand Testing Menu On Cobas 6800/8800 Systems For Sexually Transmitted Diseases